Please login to the form below

Not currently logged in
Email:
Password:

QuintilesIMS changes its name to IQVIA

Firm will focus on human data science solutions

IQVIAA year after its initial launch as QuintilesIMS, the pharma service provider has re-launched as IQVIA.

Its new name maintains parts of its original formation, with the ‘I’ representing IMS and the ‘Q’ taken from Quintiles.

However, the latter and newest part of the name - ‘via’  - is representative of “seeking to inspire and ignite real change via a new path forward”, explains Ari Bousbib, chief executive officer of IQVIA.

Bousbib added: “We launched as QuintilesIMS, then we built something transformational and that is how we became IQVIA.

“We aim to bring the potential of human data science to life to find better solutions for patients.”

The group has a slightly different offering from when it first became QuintilesIMS, which was due to a mega-merger of healthcare services provider Quintiles and information and technology group IMS, offering pharma clients an end-to-end clinical and commercial package.

Now, the newly-named group will provide solutions to healthcare companies through analytics, data science and human science, claiming expertise in research and development, real-world value and outcomes, commercialisation and technologies.

Article by
Gemma Jones

10th November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics